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1. Introduction 
Skeletal muscle from obese, insulin-resistant 
rodents is characterized by an impaired ability to 
increase glycogen formation in response to insulin 
in vivo [ 1,2] and in vitro [3--S]. Insulin stimulates 
glycogen synthesis in muscle by activating both glu- 
cose transport and the enzyme glycogen synthase 
[6,7]. In skeletal muscle of the genetically obese 
ob/ob mouse, the basal activities of the two forms 
(phosphorylated and dephosphorylated) of glycogen 
synthase and glycogen phosphorylase have been 
reported to be essentially unaltered [8]. It was thus 
assumed that the marked insulin resistance of muscle 
glycogen synthesis in obesity resulted only from 
impaired glucose transport, adefect which has been 
well documented in obese mice [3,5]. However, the 
effect of insulin on glycogen synthase in muscle from 
obese animals has not been specifically examined. 
Here we have directly investigated the activation 
of glycogen synthase by insulin in soleus muscles of 
goldthioglucose (GTG)-obese mice. Since it has been 
shown that this activation in skeletal muscle occurs 
via a mechanism independent of insulin effect on glu- 
cose transport [6,9,10], the present studies were per- 
formed in the absence of extracellular glucose. The 
results trongly suggest that the activation of glycogen 
synthase, an intracellular step of insulin action, is 
impaired in soleus muscles of obese mice. 
2. Materials and methods 
Soleus muscles were isolated from lean or GTG- 
obese mice [5,6] and preincubated for 15 min as in 
[3,5]. They were then incubated for 90 min at 37’C 
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in Krebs-Ringer bicarbonate buffer containing 20 mg 
defatted bovine albumin/ml and 2 mM pyruvate, fol- 
lowed by a 30 min incubation in the presence of vary- 
ing concentrations of insulin, or by a 10 min incuba- 
tion with 1 PM epinephrine. No glucose was present 
in the extracellular medium throughout the incuba- 
tions. At the end of the incubation, muscles were 
freezeclamped in liquid nitrogen and homogenized as 
in [ Ill. Homogenization buffers were 50 m.M Tris- 
HCl (pH 8.2), 5 mM EDTA, 100 mM KF for glycogen 
synthase; 50 mM morpholino ethane sulfonic acid 
(pH 6.5), 100 mM EDTA, 100 mM KF for glycogen 
phosphorylase. Glycogen synthase activity and gly- 
cogen content were measured as in [ 111. Glycogen 
synthase active (I) form is expressed as a’percentage 
of total (I + D) synthase activity. Glycogen phospho- 
rylase was measured as in [ 121. Phosphorylase active 
(a) form is expressed as % of total activity. Total 
enzymatic activities are expressed as nanomoles of 
substrate incorporated into glycogen per minute and 
per milligram of muscle protein. 
3. Results 
Soleus muscles were isolated from lean and GTG- 
obese mice whose characteristics are presented in 
table 1. Following GTG injection mice became mark- 
edly obese and moderately hyperglycemic, despite 
hyperinsulinemia. In this model of acquired obesity, 
insulin resistance has been demonstrated in vivo and 
in vitro [3,4]. Muscle protein and glycogen contents 
were identical in obese and control mice. While in 
soleus muscles of GTG-obese mice, glycogen synthase 
total activity was slightly increased, glycogen phos- 
phorylase was not significantly different from con- 
trols. 
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Table 1 
Characteristics of experimental mice 
November 1980 
n Lean n GTGobese P 
Weight Cd 22 ‘37.5 + 1.0 36 56.2 f 0.7 < 0.001 
Plasma 
Glucose (mg/lOO ml) 18 185.5 + 4.7 36 232.0 f 4.4 < 0.001 
Insulin (ng/ml) 18 2.1 f 0.2 34 7.2 + 1.1 < 0.005 
Soleus muscle 
Protein (mg/muscle) 12 2.33 + 0.06 12 2.21 f 0.03 ns. 
Glycogen &g/mg protein) 6 16.7 f 1.8 6 19.2 f 1.7 n.s. 
Glycogen synthase 
(nmol . mg protein-‘. min-‘) 9 23.1 f 1.2 11 28.0 f 1.5 < 0.025 
Glycogen phosphorylase 
(nmol . mg protein-‘. min-‘) 32 276 f 8 28 302 + 11 n.s. 
Plasma glucose and insulin were determined from blood samples obtained immediately before muscle 
isolation [ 31. Protein and glycogen contents, and total enzymatic activities, were measured in muscles 
at the end of incubations. Values are means f SE with the number of n determinations. Statistical 
significance was assessed by t-test for unpaired comparisons. n.s., not significant 
The activation of glycogen synthase following 
muscle exposure to varying insulin concentrations for 
30 min in the absence of extracellular glucose is shown 
in fig.1 ; this duration (30 min) of muscle exposure to 
insulin had been shown to result in a maximal activa- 
tion of glycogen synthase [ 111. In muscles from lean 
mice, insulin increased the activity ratio of glycogen 
synthase from 3 1% to 50%. Half-maximal effect 
occured at 1.5 nM insulin. In muscles from GTG-obese 
mice, insulin was much less effective than in muscles 
from controls in activating glycogen synthase, both al 
submaximal and maximal concentrations (fig.1). 
Basal glycogen synthase activity (measured in the 
absence of insulin) was not statistically different in 
.muscles from obese and lean animals. The defective 
insulin response in muscles from obese mice could 
not be explained by an increase in muscle glycogen 
content or by a decrease in the total activity of the 
enzyme (table 1). 
To investigate whether in muscles of obese mice 
glycogen synthase and glycogen phosphorylase could 
be phosphorylated by endogenous cyclic AMP-depen- 
dent protein kinase, the activity of both enzymes was 
measured following muscle exposure to epinephrine. 
Fig.2 shows that basal activities were not statistically 
different in muscles of lean and obese mice. Following 
a 10 min exposure of muscle to 1 PM epinephrine, 
conditions under which a maximal effect of epineph- 
rine was observed (not shown), glycogen synthase was 
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Fig.1. Insulin effect on glycogen synthase in soleus muscles 
of lean and obese mice. Muscles isolated from lean and gold- 
thioglucose (GTG>obese mice were incubated as in section2, 
in the absence or presence of insulin. At the end of the incu- 
bation, glycogen synthase activity was measured in muscle 
extracts as in section 2, in the absence (I form) or presence 
(I + D form) of 6.7 mM glucose 6-phosphate. The data are 
expressed as the percent of active form (I/I + D) X 100) of 
glycogen synthase. Each point is the mean * SE of 8 (GTG- 
obese) or 20 (lean) muscles. 
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Fig.2. Epinephrine effect on glycogen synthase and glycogen 
phosphorylase in soleus muscles of lean and obese mice. Mus- 
cles from lean and GTG-obese mice were incubated as in sec- 
tion 2, without (open bars) or with (hatched bars) 1 MM epi- 
nephrine. Enzyme activities were measured as in fig.1 and 
section2. The data are expressed as % of active form of gly- 
cogen synthase and of glycogen phosphorylase, and represent 
the means f SE of 5 muscles for each condition. 
inactivated and glycogen phosphorylase was activated 
with the same magnitude in muscles from obese and 
from lean animals (fig.2). 
4. Discussion 
These studies have indicated that in soleus muscles 
of obese mice the activation of glycogen synthase by 
insulin is markedly diminished. Previous studies have 
shown that muscle is the fast tissue to develop insulin 
resistance in GTG-induced obesity [4] or in genetically 
obese ob/ob [l] or mdb/mdb [13] mice. The results 
reported here suggest hat the pronounced decrease in 
insulinstimulated glycogen synthesis does not stem 
merely from a decrease in insulinactivated glucose 
transport [3,5], but also results from a diminished 
activation of glycogen synthase. Glycogen controls its 
own synthesis by affecting the interconversion of the 
two forms of glycogen synthase [ 141. This mechanism is 
unlikely to be the cause of the altered insulin respon- 
siveness since glycogen content was not increased in 
muscles from obese animals. This observation of a 
normal glycogen content in GTG-obese muscles despite 
hyperglycemia (and thus increased substrate availabi- 
lity) and hyperinsulinemia is a further indication that 
muscle glycogen synthesis is insulin-resistant in obese 
mice in vivo. 
The number of insulin receptors is decreased by 
-3O%in muscles of GTG-obese mice [3].This modest 
defect is unlikely to account for the markedly 
decreased insulin responsiveness, particularly at maxi- 
mally effective concentrations since insulin exerts 
maximal effects in soleus muscles when only a frac- 
tion of total receptors is occupied [3]. The recent 
observation [lo] that insulin-like growth factor 
(IGF-I) was much less effective in activating glycogen 
synthase in muscles of obese mice than in lean con- 
trols, whereas IGF-I binding was unaltered, also sug- 
gests that the alteration of glycogen synthase activa- 
tion is a post-receptor defect. A recent report [ 151 
has suggested that insulin would dephosphorylate a 
protein phosphatase inhibitor, resulting in an activa- 
tion of the glycogen synthase phosphatase and there- 
fore of the glycogen synthase. One step in this cas- 
cade is apparently defective in muscles of obese mice. 
The effect of epinephrine was unaltered in muscles 
of obese mice (fig.2). This observation indicates that 
cyclic AMP-dependent protein kinase is normally 
responsive to epinephrine in muscles from obese mice. 
This is in contrast with the impaired response of 
adenylate cyclase to epinephrine in adipocyte plasma 
membranes from ob/ob mice [ 16].‘0ur data also sug- 
gest that in muscles of obese mice glycogen synthase 
is still capable of being modulated by changes in 
endogenous cvclic AMP levels. 
Glycogen synthase activation by insulin is markedly 
altered in muscles of obese mice. This abnormality 
points to an intracellular defect of insulin action. In 
[ 17 J, insulin increased the concentration of a low 
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molecular weight substance in rat skeletal muscle. 
Whether the defective activation of glycogen synthase 
by insulin in muscles of obese mice may result from a 
defective mergence oreffectiveness of this putative 
‘mediator’ emains to be investigated. 
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